The older generic drug hydroxyurea, if combined with a small dose of aspirin and given to people with thrombocythemia, is more effective in preventing serious bleeding and other complications than the newer and more expensive Agrylin, according to a study.Agrylin, also known as anagrelide, is made by Roberts Pharmaceuticals, which merged with Shire Pharmaceuticals Group in 1999.
